CaseVuCategory Archives: Press Releases
Precipio Reminds Investors Of Conference Call With Management For Corporate Update And Second Quarter Results
Provides participation details for Thursday, August 23 call NEW HAVEN, CT, (August 22nd, 2018) – Specialty [...]
Aug
Precipio Announces Second Quarter 2018 Financial Results And Provides Corporate Update
Conference call with management to be held Thursday August 23, 2018 at 09:00 Eastern Time [...]
Aug
Precipio Appoints New Board Member To Replace Departing Director
Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics [...]
Aug
Precipio Announces 213% Year-Over-Year Revenue Growth In Preliminary Q2-2018 Results
Third consecutive quarter of triple-digit YoY Quarterly growth NEW HAVEN, CT, (July 18th, 2018) – Specialty [...]
Jul
Precipio And Nucleai Partner To Develop Artificial Intelligence-Powered Hemepath Solution
System will support Hematopathologists in accurately identifying abnormalities to ensure diagnostic accuracy NEW HAVEN, CT, [...]
Jun
Precipio Updates Commercial Pipeline For Its ICE-COLD PCR™ Liquid Biopsy Technology
Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, CT, (June 19th, [...]
Jun
Precipio Inc. Announces Adjournment Of Annual Meeting Of Shareholders
NEW HAVEN, CT, (June 15th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that [...]
Jun
Precipio Reminds Shareholders To Vote Before The Annual General Meeting On June 15, 2018
NEW HAVEN, CT, (June 14th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today reminded its [...]
Jun
Precipio Reminds Shareholders To Vote Before The Annual General Meeting On June 15, 2018
NEW HAVEN, CT, (June 12th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today reminded its [...]
Jun
Precipio Strengthens Patent Portfolio With Expanded Reagent Claims For Its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
NEW HAVEN, CT, (June 06th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced the [...]
Jun